In our panel, blood concentrations of CCL2, a proinflammatory chemoattractant for monocytes, were increased, as previously seen in preclinical neuropathic pain models29,30 and in patients with polyneuropathy.9 This evidence concerns the gene CCL2 and polyneuropathy.